Group is collaborating with Thai partners to supply its products and services
PETALING JAYA, Malaysia, Sept 23, 2022 - (ACN Newswire) - Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155),
a leading genomics and biopharmaceutical specialist, is pleased to announce today a series of collaborations to grow its
customer base in Thailand as well as exploring opportunities for research and development (R) of new products and services.
The Group signed a supply and collaboration agreement with Acquest Healthcare Stem Cell Research and Development Co.
Ltd. to produce CAR T-cells for supply to Acquest's customers. Acquest is a well-established provider of various cell
therapies to hospitals, specialist doctors, and patients in Thailand. It operates a state-of-the-art clinical laboratory
and also the largest privately-owned specialty human cell culturing facility in the country.
The Group also signed a supply and collaboration agreement with Salus Holdings Co. Ltd. ("Salus") to supply
biopharmaceutical and genomics products and services to Salus' customers. Salus is a specialist in wellness and health
screening using science and technology for early disease detection and managing programmes for lifestyle intervention
based in Bangkok, Thailand.
Finally, the Group signed a Letter of Intent with Marine Group Co. Ltd. and Salus on collaborative research in the use
of genetic screening tests and formulated cosmetic products containing certain cell therapy ingredients on the
regeneration of skin and hair of patients. Marine Group is an aesthetic and wellness specialist with a network of over
42 centres under the brands Slim Up(TM), Skin Doctors(TM), and Biocell(TM).
The signing ceremony was attended by His Excellency Dato' Jojie Samuel, Ambassador of Malaysia to Thailand and Encik
Mohamed Hafiz Md Shariff, Trade Commissioner of MATRADE Bangkok.
Chief Executive Officer of Malaysian Genomics, Encik Sasha Nordin, said, "We are looking forward to a fruitful
relationship with our Thai partners, Salus and Acquest. These collaborations are part of our strategy of growing our
customer base and increasing our presence overseas through working with business partners who have an established
presence in their respective market segments."
Dr. Roland Neff, CEO of Acquest, said, "This collaboration is the first step as both parties explore the possibilities
of conducting joint R that can result in new products and services that can be commercialised. We have a state-of-the-art clinical laboratory
in Bangkok and also the largest privately-owned specialty human cell culturing facility in the country."
Mr. Choy Hong Yang, Director of Salus, said, "At Salus, we use science and technology to provide services on disease
detection, prevention and life-span improvement. This collaboration with Malaysian Genomics will enable us to leverage
on their genetics knowledge and expertise to offer more products and services while the strategic cooperation is in
keeping with our core value of joint innovation to offer new technologies to our customers."
Ms. Songsuda Panich, Founder of Marine Group, said, "Skin Doctor, Slim Up and BioCell centres are always striving to
provide the latest in skin and aesthetic science and technology for our customers. We look forward to collaborating with
Malaysian Genomics and with Salus Healthcare on research and development involving cell regeneration products."
Malaysian Genomics Resource Centre Berhad: 0155 [BURSA: MGRC] [RIC: MGRC:KL] [BBG: MGRC:MK],